Research Article
BibTex RIS Cite

The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients

Year 2023, , 855 - 862, 29.12.2023
https://doi.org/10.33808/clinexphealthsci.1203235

Abstract

Objective: Implantable cardioverter defibrillators (ICDs), which are used in the treatment of fatal ventricular arrhythmias, have many life-saving benefits. On the other hand, it has negative effects in terms of physical, social and psychological aspects by commonly causing anxiety and depression. The aim of this study is to examine the effects of education and telephone monitoring on self-efficacy and shock anxiety in patients with implantable cardioverter defibrillator implantation.
Methods: 65 patients hospitalized for ICD insertion were randomly divided into intervention (n=33) and control (n=32) groups. The intervention group was given a training booklet prepared by one-on-one training about ICD. Telephone monitoring was performed once every two weeks for three months and then once a month. No intervention was applied to the control group. Self-Efficacy and Outcome Expectation Scales, Florida Shock Anxiety Scale were applied in the third and sixth months after ICD implantation in both groups.
Results: The self-efficacy scores at the sixth month were higher in the intervention group than in the control group (p=.03). There was no difference between the shock anxiety scores at 3 months (p=.58) and 6 months (p=.64) between the groups. Shock anxiety mean scores of both groups in the 6th month are lower than the mean scores in the 3rd month (p<.01). It was found that self-efficacy and outcome expectation scores decreased as shock anxiety scores increased.
Conclusion: It was determined that the intervention increased the level of self-efficacy and did not make a difference in terms of and shock anxiety. It should be aimed to reduce shock anxiety and accompanying physical problems by supporting patients with various nursing interventions that will increase self-efficacy during adjustment periods.

References

  • Dougherty CM, Pyper GP, Frasz HA. Description of nursing intervention program after an implantable cardioverter defibrillator. Heart & Lung 2004;33(3):183-190. DOI: 10.1016/j.hrtlng.2004.01.003
  • Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ, & ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal 2015;36(41):2793–2867. DOI:10.1093/eurheartj/ehv316
  • Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Journal of the American College of Cardiology 2018;72(14):e91–e220. DOI:10.1016/j.jacc.2017.10.054 .
  • Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart & Lung 2013; 42:105-111. DOI:10.1016/j.hrtlng.2012.08.006
  • Berg SK, Støier L, Moons P, Zwisler AD, Winkel P, Pedersen PU. Emotions and health findings from a randomized clinical trial on psychoeducational nursing to patients with implantable cardioverter defibrillator. J Cardiovasc Nurs. 2015;30(3):197-204. DOI: 10.1097/JCN.0000000000000132
  • Dougherty CM, Luttrell MN, Burr RL, Kim M, Haskell WL. Adherence to an aerobic exercise intervention after an implantable cardioverter defibrillator (ICD). Pacing Clinical Electrophysiology 2016;39:128-139. DOI:10.1111/pace.12782
  • Hirsh AT, Sears SF, Conti JB. Cognitive and behavioral treatments for anxiety and depression in a patient with an ımplantable cardioverter defibrillator (ICD): A case report and clinical discussion. J Clin Psychol Med Settings 2009;16:270-279. DOI: 10.1007/s10880-009-9160-0
  • Maia ACCO, Braga AA, Soares-Filho G, Pereira V, Nardi AE, Silva AC. Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review. Brazilian Journal of Medical and Biological Research 2014;47:265-272. DOI:10.1590/1414-431X20133418
  • Sears SF, Lewis TS, Kuhl EA, & Conti JB. Predictors of quality of life in patients with ımplantable cardioverter defibrillators. Psychosomatics 2005;46:451-457. DOI:10.1176/appi.psy.46.5.451
  • Cook SC, Valente AM, Maul TM, Dew MA, Hickey J, Burger J, Harmon A, Clair M, Webster G, Cecchin F, Khairy P. Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter- defibrillators. Heart Rhythm 2013;10(6):805-810. DOI:10.1016/j.hrthm.2013.02.016
  • Van Den Broek KC, Heijmans N, Van Assen M. Anxiety and depression in patients with an implantable cardioverter defibrillator and their partners: A longitudinal study. Pacing Clin Electrophysiol 2013;36:362-371. DOI:10.1111/pace.12055
  • Ansari S, Arbabi M. Cognitive behavioral therapy (CBT) in a patient with implantable cardioverter defibrillator (ICD) and posttraumatic stress disorder (PTSD). Iran J Psychiatry 2014;9(3):181-183.
  • Ford J, Finch JF, Woodrow LK, Cutitta KE, Shea J, Fischer A, Hazelton G, Sears SF. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure. Pacing and Clinical Electrophysiology 2012;35(9):1146–1153. DOI:10.1111/j.1540-8159.2012.03455.x
  • Morken IM, Bru E, Norekvål TM, Larsen AI, Idsoe T, Karlsen B. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients. Journal of Clinical Nursing 2014;23(3-4):450–460. DOI:10.1111/jocn.12200
  • Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology 2006;29(6):614–618. DOI:10.1111/j.1540-8159.2006.00408.x
  • Pedersen SS, Theuns DA, Jordaens L, Kupper N. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace 2010;12(8):1119–1126. DOI:10.1093/europace/euq154
  • Çinar FI, Tosun N, Kose S. Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients. Journal of Clinical Nursing 2013;22(17-18): 2474–2486. DOI:10.1111/jocn.12201
  • Qintar M, George JJ, Panko M, Bea S, Broer KA, St John J, Blissett KA, Ching E, Sears SF, Pedersen SS, Pozuelo L, Chung MK. A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. Journal of Interventional Cardiac Electrophysiology 2015;43(1):65–75. DOI:10.1007/s10840-015-9990-7
  • Kılıçlı AB, Özdemir L. Psychosocial adjustment in heart failure patients with cardioverter defibrillator implantation. Journal of Anatolia Nursing and Health Sciences 2017; 20:41-47.
  • Dougherty CM, Johnston SK, Thompson EA. Reliability and validity of the self-efficacy expectations and outcome expectations after implantable cardioverter defibrillator implantation scales. Applied Nursing Research 2007;20(3):116–124. DOI:10.1016/j.apnr.2007.04.004
  • Carlsson E, Olsson SB, Hertervig E. The role of the nurse in enhancing quality of life in patients with an implantable cardioverter-defibrillator: The Swedish experience. Progress in Cardiovascular Nursing 2002;17(1):18–25. DOI:10.1111/j.0889-7204.2002.00613.x
  • Tagney J. Can nurses in cardiology areas prepare patients for implantable cardioverter defibrillator implant and life at home?. Nursing in Critical Care 2004;9(3):104–114. DOI:10.1111/j.1362-1017.2004.00064.x
  • Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing and Clinical Electrophysiology 2009;32(10):1259–1271. DOI:10.1111/j.1540-8159.2009.02495.x
  • Alkan H. İmplante Edilebilen Kardiyoverter Defibrilatör Hastalarında Psikososyal Faktörlerin İncelenmesi. İ.Ü. Sağlık Bilimleri Enstitüsü, Doktora Tezi, 2014, İstanbul (Danışman: Prof. Dr. Nuray Enç) (Turkish).
  • Alkan OH, Enc N. Validity and reliability of the Florida Patient Acceptance Survey and Florida Shock Anxiety Scale in Turkish patients with implantable cardioverter defibrillation. International Journal of Medical Research & Health Sciences 2017; 6(10):21- 32.
  • Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003;5(4):381–389. DOI:10.1016/s1099-5129(03)00078-3
  • Dougherty CM, Thompson EA, Lewis FM. Long-term outcomes of a telephone intervention after an ICD. Pacing and Clinical Electrophysiology 2005;28(11):1157–1167. DOI:10.1111/j.1540-8159.2005.09500.x
  • Bandura A. Self-efficacy the exercise of control. New York: W. H. Freeman; 1997.
  • Cowan MJ, Pike KC, Budzynski HK. Psychosocial nursing therapy following sudden cardiac arrest: impact on two-year survival. Nursing Research 2001;50(2):68–76. DOI:10.1097/00006199-200103000-00002
  • Smeulders ES, van Haastregt JC, Dijkman-Domanska BK, van Hoef EF, van Eijk JT, Kempen GI. Nurse and peer led self management programme for patients with an implantable cardioverter defibrillator; A feasibility study. BMC Nursing 2007;6:6. DOI:10.1186/1472-6955-6-6
  • Yardımcı T, Mert H. Web-Based intervention to improve implantable cardioverter defibrillator patients' shock-related anxiety and quality of life: A randomized controlled trial. Clinical Nursing Research 2019;28(2):150–164. DOI:10.1177/1054773817741427
  • Flemme I, Johansson I, Strömberg A. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients. Journal of Clinical Nursing 2012;21(3-4):311–321. DOI:10.1111/j.1365-2702.2011.03847.x
  • Tripp C, Huber NL, Kuhl EA, Sears SF. Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use. Pacing and Clinical Electrophysiology 2019;42(10):1294–1301. DOI:10.1111/pace.13793
  • Mauro AM. Exploring uncertainty and psychosocial adjustment after cardioverter defibrillator implantation. The Journal of Cardiovascular Nursing 2008;23(6):527–535. DOI:10.1097/01.JCN.0000338932.73963.42
  • Mert H, Argon G, Aslan O. Experiences of patients with implantable cardioverter defibrillator in Turkey: A qualitative study. International Journal of Caring Sciences 2012;5(1):50-55.
  • Salmoirago-Blotcher E, Crawford SL, Carmody J, Rosenthal L, Yeh G, Stanley M, Rose K, Browning C, & Ockene IS. Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: Results of a pilot randomized controlled trial. Annals of Behavioral Medicine 2013;46(2):243–250. DOI:10.1007/s12160-013-9505-7
  • Kao CW, Chen MY, Chen TY, Lin PH. Effect of psycho-educational interventions on quality of life in patients with implantable cardioverter defibrillators: A meta-analysis of randomized controlled trials. Health and Quality of Life Outcomes 2016;14(1):138. DOI:10.1186/s12955-016-0543-2
  • Chair SY, Lee CK, Choi KC, Sears SF. Quality of life outcomes in Chinese patients with implantable cardioverter defibrillators. Pacing and Clinical Electrophysiology 2011;34(7):858–867. DOI:10.1111/j.1540-8159.2011.03048.x
  • Mlynarska A, Mlynarski R, Uchmanowicz I, Marcisz C, Golba KS. The Relationship between frailty syndrome and concerns about an implantable cardioverter defibrillator. International Journal of Environmental Research and Public Health 2020;17(6):1954. DOI:10.3390/ijerph17061954
  • Humphreys NK, Lowe R, Rance J, Bennett PD. Living with an implantable cardioverter defibrillator: The patients' experience. Heart & Lung 2016;45(1):34–40. DOI:10.1016/j.hrtlng.2015.10.001
  • Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E, Kneipp SM, Zineh I, Conti JB. The ICD shock and stress management program: A randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing and Clinical Electrophysiology 2007;30(7):858–864. DOI:10.1111/j.1540-8159.2007.00773.x
  • Toise SC, Sears SF, Schoenfeld MH, Blitzer ML, Marieb MA, Drury JH, Slade MD, Donohue TJ. Psychosocial and cardiac outcomes of yoga for ICD patients: A randomized clinical control trial. Pacing and Clinical Electrophysiology 2014;37(1):48–62. DOI:10.1111/pace.12252
Year 2023, , 855 - 862, 29.12.2023
https://doi.org/10.33808/clinexphealthsci.1203235

Abstract

References

  • Dougherty CM, Pyper GP, Frasz HA. Description of nursing intervention program after an implantable cardioverter defibrillator. Heart & Lung 2004;33(3):183-190. DOI: 10.1016/j.hrtlng.2004.01.003
  • Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ, & ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal 2015;36(41):2793–2867. DOI:10.1093/eurheartj/ehv316
  • Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Journal of the American College of Cardiology 2018;72(14):e91–e220. DOI:10.1016/j.jacc.2017.10.054 .
  • Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart & Lung 2013; 42:105-111. DOI:10.1016/j.hrtlng.2012.08.006
  • Berg SK, Støier L, Moons P, Zwisler AD, Winkel P, Pedersen PU. Emotions and health findings from a randomized clinical trial on psychoeducational nursing to patients with implantable cardioverter defibrillator. J Cardiovasc Nurs. 2015;30(3):197-204. DOI: 10.1097/JCN.0000000000000132
  • Dougherty CM, Luttrell MN, Burr RL, Kim M, Haskell WL. Adherence to an aerobic exercise intervention after an implantable cardioverter defibrillator (ICD). Pacing Clinical Electrophysiology 2016;39:128-139. DOI:10.1111/pace.12782
  • Hirsh AT, Sears SF, Conti JB. Cognitive and behavioral treatments for anxiety and depression in a patient with an ımplantable cardioverter defibrillator (ICD): A case report and clinical discussion. J Clin Psychol Med Settings 2009;16:270-279. DOI: 10.1007/s10880-009-9160-0
  • Maia ACCO, Braga AA, Soares-Filho G, Pereira V, Nardi AE, Silva AC. Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review. Brazilian Journal of Medical and Biological Research 2014;47:265-272. DOI:10.1590/1414-431X20133418
  • Sears SF, Lewis TS, Kuhl EA, & Conti JB. Predictors of quality of life in patients with ımplantable cardioverter defibrillators. Psychosomatics 2005;46:451-457. DOI:10.1176/appi.psy.46.5.451
  • Cook SC, Valente AM, Maul TM, Dew MA, Hickey J, Burger J, Harmon A, Clair M, Webster G, Cecchin F, Khairy P. Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter- defibrillators. Heart Rhythm 2013;10(6):805-810. DOI:10.1016/j.hrthm.2013.02.016
  • Van Den Broek KC, Heijmans N, Van Assen M. Anxiety and depression in patients with an implantable cardioverter defibrillator and their partners: A longitudinal study. Pacing Clin Electrophysiol 2013;36:362-371. DOI:10.1111/pace.12055
  • Ansari S, Arbabi M. Cognitive behavioral therapy (CBT) in a patient with implantable cardioverter defibrillator (ICD) and posttraumatic stress disorder (PTSD). Iran J Psychiatry 2014;9(3):181-183.
  • Ford J, Finch JF, Woodrow LK, Cutitta KE, Shea J, Fischer A, Hazelton G, Sears SF. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure. Pacing and Clinical Electrophysiology 2012;35(9):1146–1153. DOI:10.1111/j.1540-8159.2012.03455.x
  • Morken IM, Bru E, Norekvål TM, Larsen AI, Idsoe T, Karlsen B. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients. Journal of Clinical Nursing 2014;23(3-4):450–460. DOI:10.1111/jocn.12200
  • Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology 2006;29(6):614–618. DOI:10.1111/j.1540-8159.2006.00408.x
  • Pedersen SS, Theuns DA, Jordaens L, Kupper N. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace 2010;12(8):1119–1126. DOI:10.1093/europace/euq154
  • Çinar FI, Tosun N, Kose S. Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients. Journal of Clinical Nursing 2013;22(17-18): 2474–2486. DOI:10.1111/jocn.12201
  • Qintar M, George JJ, Panko M, Bea S, Broer KA, St John J, Blissett KA, Ching E, Sears SF, Pedersen SS, Pozuelo L, Chung MK. A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. Journal of Interventional Cardiac Electrophysiology 2015;43(1):65–75. DOI:10.1007/s10840-015-9990-7
  • Kılıçlı AB, Özdemir L. Psychosocial adjustment in heart failure patients with cardioverter defibrillator implantation. Journal of Anatolia Nursing and Health Sciences 2017; 20:41-47.
  • Dougherty CM, Johnston SK, Thompson EA. Reliability and validity of the self-efficacy expectations and outcome expectations after implantable cardioverter defibrillator implantation scales. Applied Nursing Research 2007;20(3):116–124. DOI:10.1016/j.apnr.2007.04.004
  • Carlsson E, Olsson SB, Hertervig E. The role of the nurse in enhancing quality of life in patients with an implantable cardioverter-defibrillator: The Swedish experience. Progress in Cardiovascular Nursing 2002;17(1):18–25. DOI:10.1111/j.0889-7204.2002.00613.x
  • Tagney J. Can nurses in cardiology areas prepare patients for implantable cardioverter defibrillator implant and life at home?. Nursing in Critical Care 2004;9(3):104–114. DOI:10.1111/j.1362-1017.2004.00064.x
  • Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing and Clinical Electrophysiology 2009;32(10):1259–1271. DOI:10.1111/j.1540-8159.2009.02495.x
  • Alkan H. İmplante Edilebilen Kardiyoverter Defibrilatör Hastalarında Psikososyal Faktörlerin İncelenmesi. İ.Ü. Sağlık Bilimleri Enstitüsü, Doktora Tezi, 2014, İstanbul (Danışman: Prof. Dr. Nuray Enç) (Turkish).
  • Alkan OH, Enc N. Validity and reliability of the Florida Patient Acceptance Survey and Florida Shock Anxiety Scale in Turkish patients with implantable cardioverter defibrillation. International Journal of Medical Research & Health Sciences 2017; 6(10):21- 32.
  • Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003;5(4):381–389. DOI:10.1016/s1099-5129(03)00078-3
  • Dougherty CM, Thompson EA, Lewis FM. Long-term outcomes of a telephone intervention after an ICD. Pacing and Clinical Electrophysiology 2005;28(11):1157–1167. DOI:10.1111/j.1540-8159.2005.09500.x
  • Bandura A. Self-efficacy the exercise of control. New York: W. H. Freeman; 1997.
  • Cowan MJ, Pike KC, Budzynski HK. Psychosocial nursing therapy following sudden cardiac arrest: impact on two-year survival. Nursing Research 2001;50(2):68–76. DOI:10.1097/00006199-200103000-00002
  • Smeulders ES, van Haastregt JC, Dijkman-Domanska BK, van Hoef EF, van Eijk JT, Kempen GI. Nurse and peer led self management programme for patients with an implantable cardioverter defibrillator; A feasibility study. BMC Nursing 2007;6:6. DOI:10.1186/1472-6955-6-6
  • Yardımcı T, Mert H. Web-Based intervention to improve implantable cardioverter defibrillator patients' shock-related anxiety and quality of life: A randomized controlled trial. Clinical Nursing Research 2019;28(2):150–164. DOI:10.1177/1054773817741427
  • Flemme I, Johansson I, Strömberg A. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients. Journal of Clinical Nursing 2012;21(3-4):311–321. DOI:10.1111/j.1365-2702.2011.03847.x
  • Tripp C, Huber NL, Kuhl EA, Sears SF. Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use. Pacing and Clinical Electrophysiology 2019;42(10):1294–1301. DOI:10.1111/pace.13793
  • Mauro AM. Exploring uncertainty and psychosocial adjustment after cardioverter defibrillator implantation. The Journal of Cardiovascular Nursing 2008;23(6):527–535. DOI:10.1097/01.JCN.0000338932.73963.42
  • Mert H, Argon G, Aslan O. Experiences of patients with implantable cardioverter defibrillator in Turkey: A qualitative study. International Journal of Caring Sciences 2012;5(1):50-55.
  • Salmoirago-Blotcher E, Crawford SL, Carmody J, Rosenthal L, Yeh G, Stanley M, Rose K, Browning C, & Ockene IS. Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: Results of a pilot randomized controlled trial. Annals of Behavioral Medicine 2013;46(2):243–250. DOI:10.1007/s12160-013-9505-7
  • Kao CW, Chen MY, Chen TY, Lin PH. Effect of psycho-educational interventions on quality of life in patients with implantable cardioverter defibrillators: A meta-analysis of randomized controlled trials. Health and Quality of Life Outcomes 2016;14(1):138. DOI:10.1186/s12955-016-0543-2
  • Chair SY, Lee CK, Choi KC, Sears SF. Quality of life outcomes in Chinese patients with implantable cardioverter defibrillators. Pacing and Clinical Electrophysiology 2011;34(7):858–867. DOI:10.1111/j.1540-8159.2011.03048.x
  • Mlynarska A, Mlynarski R, Uchmanowicz I, Marcisz C, Golba KS. The Relationship between frailty syndrome and concerns about an implantable cardioverter defibrillator. International Journal of Environmental Research and Public Health 2020;17(6):1954. DOI:10.3390/ijerph17061954
  • Humphreys NK, Lowe R, Rance J, Bennett PD. Living with an implantable cardioverter defibrillator: The patients' experience. Heart & Lung 2016;45(1):34–40. DOI:10.1016/j.hrtlng.2015.10.001
  • Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E, Kneipp SM, Zineh I, Conti JB. The ICD shock and stress management program: A randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing and Clinical Electrophysiology 2007;30(7):858–864. DOI:10.1111/j.1540-8159.2007.00773.x
  • Toise SC, Sears SF, Schoenfeld MH, Blitzer ML, Marieb MA, Drury JH, Slade MD, Donohue TJ. Psychosocial and cardiac outcomes of yoga for ICD patients: A randomized clinical control trial. Pacing and Clinical Electrophysiology 2014;37(1):48–62. DOI:10.1111/pace.12252
There are 42 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases Nursing​
Journal Section Articles
Authors

Berna Akay 0000-0002-8316-6545

Sıdıka Oğuz 0000-0002-1101-1923

Publication Date December 29, 2023
Submission Date November 12, 2022
Published in Issue Year 2023

Cite

APA Akay, B., & Oğuz, S. (2023). The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients. Clinical and Experimental Health Sciences, 13(4), 855-862. https://doi.org/10.33808/clinexphealthsci.1203235
AMA Akay B, Oğuz S. The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients. Clinical and Experimental Health Sciences. December 2023;13(4):855-862. doi:10.33808/clinexphealthsci.1203235
Chicago Akay, Berna, and Sıdıka Oğuz. “The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients”. Clinical and Experimental Health Sciences 13, no. 4 (December 2023): 855-62. https://doi.org/10.33808/clinexphealthsci.1203235.
EndNote Akay B, Oğuz S (December 1, 2023) The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients. Clinical and Experimental Health Sciences 13 4 855–862.
IEEE B. Akay and S. Oğuz, “The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients”, Clinical and Experimental Health Sciences, vol. 13, no. 4, pp. 855–862, 2023, doi: 10.33808/clinexphealthsci.1203235.
ISNAD Akay, Berna - Oğuz, Sıdıka. “The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients”. Clinical and Experimental Health Sciences 13/4 (December 2023), 855-862. https://doi.org/10.33808/clinexphealthsci.1203235.
JAMA Akay B, Oğuz S. The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients. Clinical and Experimental Health Sciences. 2023;13:855–862.
MLA Akay, Berna and Sıdıka Oğuz. “The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients”. Clinical and Experimental Health Sciences, vol. 13, no. 4, 2023, pp. 855-62, doi:10.33808/clinexphealthsci.1203235.
Vancouver Akay B, Oğuz S. The Effect of Education, Telephone Monitoring on Self-Efficacy and Shock Anxiety of Implantable Cardioverter Defibrillator Patients. Clinical and Experimental Health Sciences. 2023;13(4):855-62.

14639   14640